SCH-900105 in Recurrent Glioblastoma

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Glioblastoma
Interventions
DRUG

SCH 900105

10 mg/kg by vein every week on days 1, 8 and 15 of a 30 day cycle.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER